Why is Beryl Drugs falling/rising?

As of 22-Sep, Beryl Drugs Ltd is experiencing a price increase, with the current price at 22.98, reflecting a change of 0.14 or 0.61% upward. The stock has outperformed its sector today by 1.69%. However, despite this positive movement, the stock has shown a significant decline over the year-to-date, down 36.43%, and has a negative return of 34.66% over the past year. Additionally, the stock's delivery volume has fallen sharply by 64.44% against the 5-day average, indicating a decrease in investor participation, which could be a concern for future price stability. There is no information available regarding positive or negative factors that could further explain the stock's recent movement.
In the broader market context, Beryl Drugs' short-term performance over the past week shows a decline of 5.12%, contrasting with the Sensex, which has increased by 0.46%. This underperformance relative to the benchmark may contribute to investor caution. However, over the longer term, the stock has significantly outperformed the Sensex over the past three years, with a return of 142.15% compared to the benchmark's 38.97%, suggesting that while recent trends are concerning, the stock has had a strong historical performance that may still attract long-term investors.